Management of Fluoropyrimidine-Induced Cardiac Adverse Outcomes Following Cancer TreatmentMohsen Rajaeinejad, Babak Arjmand, Mehran Khoshfetrat et al.|Cardiovascular Toxicology|2024Cited by 10